NXTS ▲ +16.5% - Nexentis Technologies Inc.
$NXTS - Nexentis: MitoCareX Strengthens Its Computational Drug Discovery Capabilities with Appointment of Prof. Dan T. Major to Scientific Advisory Board
24-SEP-2026 07:50 AM ET
Share this post
More filings for $NXTS
NXTS ▲ +10.6% - Nexentis Technologies Inc.Sep 23, 2026$NXTS SEC Filing Update (15-JUL-2026) | ThinkSabio - Stocks SimplifiedJul 15, 2026
View full $NXTS filing history →💬 Comments
Loading comments…
Leave a comment